Auspex Pharmaceuticals' IPO

Auspex Pharmaceuticals raised a round of funding on February 05, 2014. Investors include Public.

Auspex Pharmaceuticals is a privately held biopharmaceutical company focused on the use of deuterium in medicinal chemistry, and the treatment of hyperkinetic movement disorders including Huntington's…

Articles about Auspex Pharmaceuticals' IPO: